osimertinib
astrazeneca
['adaura', 'sclc', 'lung', 'lcsm,(-blcsm)', 'osimertinib', 'nsclc', 'aura ,(-laura)']
overall survival analysis from the adaura trial of adjuvant osimertinib in patients with resected egfr mutated (egfrm) stage ib iiia non-small cell lung cancer (nsclc) [2023] et al. #asco23 lba3 #lcsm #precisionmedicine
Views my own. VP Clinical Partnerships @TempusLabs #PrecisionMedicine #mmsm #lymsm #CCC19 @COVID19nCCC @ASCO COI: https://t.co/5eGVEN2woA…